Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Vertanical GmbH is active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This action is under review by 1 distinct examiner, indicating a focus for the company's current patent office interactions. The prosecution is situated within a distinct art unit, which reflects a specific technical classification for the pending application. This narrow administrative footprint suggests that the company's current legal efforts are concentrated on a particular innovation within the broader biotechnology sector.
The busiest examiner for the portfolio is BOECKELMAN, JACOB A, who is overseeing the pending office action. As this examiner is the only individual currently assigned to a pending action, the individual examination style is the primary variable in the company's immediate prosecution path. The concentration of the pending action within the art unit and under the examiner suggests that the company's current USPTO activity is highly centralized. For practitioners, this means that the success of the current filing depends on meeting the specific criteria and interpretations of the examiner within the Biotechnology & Pharmaceuticals field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKELMAN, JACOB A | 1 | 34.9% | +46.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18833550 | METHOD FOR THE PRODUCTION OF A PLANT EXTRACT | BOECKELMAN, JACOB A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18833550 | METHOD FOR THE PRODUCTION OF A PLANT EXTRACT | BOECKELMAN, JACOB A | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18833550 | METHOD FOR THE PRODUCTION OF A PLANT EXTRACT | BOECKELMAN, JACOB A | 1655 | §102§103§112 | Non-Final OA | — | Pending | Jul 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVertanical GmbH has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jacob A Boeckelman has the most, with 1 of Vertanical GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
